Authors:
PUI CH
RELLING MV
LASCOMBES F
HARRISON PL
STRUXIANO A
MONDESIR JM
RIBEIRO RC
SANDLUND JT
RIVERA GK
EVANS WE
MAHMOUD HH
Citation: Ch. Pui et al., URATE OXIDASE IN PREVENTION AND TREATMENT OF HYPERURICEMIA ASSOCIATEDWITH LYMPHOID MALIGNANCIES, Leukemia, 11(11), 1997, pp. 1813-1816
Authors:
KESSLER M
GRUNFELD J
LASCOMBES F
NECCIARI J
Citation: M. Kessler et al., PHARMACOKINETICS OF TILUDRONATE IN PATIENTS WITH CHRONIC SEVERE RENAL-FAILURE, Journal of bone and mineral research, 11, 1996, pp. 662-662
Citation: F. Jacob et al., TILUDRONATE - PHARMACOKINETIC DOSE PROPORTIONALITY AFTER INTRAVENOUS ADMINISTRATION - ABSOLUTE BIOAVAILABILITY IN HEALTHY-VOLUNTEERS, Journal of bone and mineral research, 11, 1996, pp. 663-663
Authors:
CHASSARD D
LASCOMBES F
CREEK R
NECCIARI J
Citation: D. Chassard et al., STUDY OF THE PHARMACOKINETIC INTERACTION BETWEEN TILUDRONATE AND THE NONSTEROIDAL ANTIINFLAMMATORY DRUGS - ASPIRIN, DICLOFENAC AND INDOMETHACIN, Journal of bone and mineral research, 11, 1996, pp. 664-664
Authors:
ROYERMORROT MJ
ZHIRI A
JACOB F
NECCIARI J
LASCOMBES F
ROYER RJ
Citation: Mj. Royermorrot et al., INFLUENCE OF FOOD-INTAKE ON THE PHARMACOKINETICS OF A SUSTAINED-RELEASE FORMULATION OF SODIUM VALPROATE, Biopharmaceutics & drug disposition, 14(6), 1993, pp. 511-518